Answers are grounded in this paper and cite their sources.
Evaluates thermal effects on Cr2O3 nanoparticles in antibacterial applications, suggesting optimal conditions.
Chromium(III) oxide nanoparticles (Cr2O3 NPs) were synthesized via a sol–gel method and calcined at 300, 400, and 500 °C to examine the influence of thermal treatment on structural, magnetic, and antibacterial properties. XRD confirmed the formation of phase-pure α- Cr2O3 at all temperatures, with enhanced crystallinity and reduced microstrain observed at 400 °C. Williamson–Hall analysis showed crystallite sizes of ~15.7 nm (300 °C), ~19.2 nm (400 °C), and ~14.9 nm (500 °C). FTIR spectra indicated progressive removal of residual hydroxyl and nitrate groups with increasing temperature, while TEM revealed improved particle uniformity at 400 °C. VSM analysis of Cr2O3 NPs calcined at 500 °C exhibited weak ferromagnetic behavior with a maximum magnetization of ~0.09 emu g⁻¹, remanent magnetization of ~0.025 emu g⁻¹, and low coercivity (~120), attributed to surface spin canting in the nanoparticles. Antibacterial studies against Streptococcus pneumoniae showed maximum inhibition at 400 °C, highlighting its optimal physicochemical and biological performance for biomedical applications.
No takes yet. Share an insight, caveat, or question.
Ali et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: